The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Kailash Shantilal Choudhari
AKSHOPTFBR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Kailash Shantilal Choudhari, Promoter and Director of Aksh Optifibre Ltd, has sold 13,747 equity shares (0.01% of paid-up capital) through the open market on December 30, 2025. His personal holding reduced from 42,65,992 shares (2.62%) to 42,52,245 shares (2.61%). Along with Persons Acting in Concert (PAC) — Rohan Rashi Family Trust, Mrs. Mona Choudhari, Mr. Rohan Choudhari, and Ms. Rashi Choudhari — the combined promoter group holds 93,01,000 shares, or 5.71% of the company. The disclosure was filed under SEBI SAST Regulation 29(2), which mandates reporting of every acquisition or sale of shares by promoters.
This is a very small sale by a promoter with no material impact on ownership or control; the combined promoter group holding remains at 5.71%, so retail investors are unlikely to see any meaningful effect on share price or voting dynamics.